A detailed history of Macquarie Group LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Macquarie Group LTD holds 2,218,849 shares of JNJ stock, worth $324 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
2,218,849
Previous 2,367,356 6.27%
Holding current value
$324 Million
Previous $346 Million 3.92%
% of portfolio
0.4%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $21.6 Million - $24.9 Million
-148,507 Reduced 6.27%
2,218,849 $360 Million
Q2 2024

Aug 09, 2024

SELL
$144.38 - $157.78 $8.5 Million - $9.29 Million
-58,875 Reduced 2.43%
2,367,356 $346 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $21.3 Million - $22.3 Million
-136,971 Reduced 5.34%
2,426,231 $384 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $57.6 Million - $62.9 Million
-395,808 Reduced 13.38%
2,563,202 $402 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $91.3 Million - $102 Million
-586,485 Reduced 16.54%
2,959,010 $461 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $46.5 Million - $50 Million
-301,186 Reduced 7.83%
3,545,495 $587 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $33.3 Million - $39.7 Million
220,481 Added 6.08%
3,846,681 $596 Million
Q4 2022

Feb 21, 2023

SELL
$160.2 - $179.79 $13.4 Million - $15 Million
-83,572 Reduced 2.25%
3,626,200 $641 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $43.2 Million - $48.1 Million
-267,714 Reduced 6.73%
3,709,772 $606 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $71.5 Million - $79.1 Million
-425,052 Reduced 9.65%
3,977,486 $706 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $31.4 Million - $35.7 Million
-198,511 Reduced 4.31%
4,402,538 $780 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $49.9 Million - $55.4 Million
-320,279 Reduced 6.51%
4,601,049 $787 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $27.5 Million - $30.6 Million
-170,349 Reduced 3.35%
4,921,328 $795 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $27.6 Million - $29.6 Million
173,118 Added 3.52%
5,091,677 $839 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $15.1 Million - $16.8 Million
-98,834 Reduced 1.97%
4,918,559 $808 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $20.8 Million - $23.9 Million
-151,972 Reduced 2.94%
5,017,393 $790 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $4 Million - $4.38 Million
28,475 Added 0.55%
5,169,365 $770 Million
Q2 2020

Aug 11, 2020

SELL
$128.81 - $155.51 $70.5 Million - $85.1 Million
-547,008 Reduced 9.62%
5,140,890 $723 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $136 Million - $188 Million
-1,219,922 Reduced 17.66%
5,687,898 $746 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $107 Million - $123 Million
838,675 Added 13.82%
6,907,820 $1.01 Billion
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $14.2 Million - $15.9 Million
112,042 Added 1.88%
6,069,145 $785 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $919,886 - $1.01 Million
7,014 Added 0.12%
5,957,103 $830 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $8.91 Million - $9.9 Million
70,847 Added 1.21%
5,950,089 $832 Million
Q4 2018

Feb 15, 2019

SELL
$122.84 - $147.84 $31.1 Million - $37.5 Million
-253,572 Reduced 4.13%
5,879,242 $759 Million
Q3 2018

Nov 15, 2018

SELL
$121.58 - $142.88 $7.1 Million - $8.35 Million
-58,430 Reduced 0.94%
6,132,814 $847 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $72 Million - $79.5 Million
603,420 Added 10.8%
6,191,244 $751 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $6.57 Million - $7.78 Million
52,514 Added 0.95%
5,587,824 $716 Million
Q4 2017

Feb 15, 2018

SELL
$131.22 - $143.62 $19.6 Million - $21.5 Million
-149,722 Reduced 2.63%
5,535,310 $771 Million
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $736 Million - $770 Million
5,685,032
5,685,032 $739 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.